Home > Result Summaries: Compounds > Combined Reduced Antigen Content Diphtheria, Tetanus, Acellular Pertussis, Inactivated Polio Vaccine Result Summaries: Combined Reduced Antigen Content Diphtheria, Tetanus, Acellular Pertussis, Inactivated Polio Vaccine GSKStudy ID Phase Title Summary (Download) 110947 phase 4 Evaluation of GSK Biological’s dTpa-IPV booster vaccine in children and adolescents, 5 years after previous dTpa-IPV boosting. (4 citation(s)) 111763 phase 3 Immunogenicity and safety of GSK Biologicals’ dTpa-IPV vaccine (Boostrix Polio) as a booster dose in 3 and 4-year-old children (0 citation(s)) 111815 phase 3 Immunogenicity and safety of GSK Biologicals’ dTpa-IPV vaccine (Boostrix Polio) as a booster dose in 5 to 6-year-old children. (3 citation(s)) 113060 phase 4 Evaluation of GSK Biologicals’ BoostrixTM Polio in healthy adults, 10 years after a booster vaccination (0 citation(s)) 711866/006 Phase 3 A phase III, open study to evaluate the immunogenicity, safety and reactogenicity of GSK Bios’ dTpa-IPV vaccine when administered as a booster vaccination to healthy children (6-8 Y) and previously vaccinated with 4 doses of DTPw and at least 3 doses of OPV/ IPV vaccines (1 citation(s))
